{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:14:26Z","timestamp":1783548866459,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40618-016-0555-0","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T11:30:03Z","timestamp":1474630203000},"page":"257-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Natural course of mild Graves\u2019 orbitopathy: is it a chronic remitting or a transient disease?"],"prefix":"10.1007","volume":"40","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Boboridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Adamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"555_CR1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update. J Endocrinol Invest 37:691\u2013700","journal-title":"J Endocrinol Invest"},{"key":"555_CR2","doi-asserted-by":"publisher","unstructured":"Anagnostis P, Adamidou F, Poulasouchidou M, Karras S (2013) Severe eyelid oedema in Graves\u2019 ophthalmopathy. BMJ Case Rep 2013. doi: 10.1136\/bcr-2013-010305","DOI":"10.1136\/bcr-2013-010305"},{"key":"555_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1530\/eje.0.1460751","volume":"146","author":"C Terwee","year":"2002","unstructured":"Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W (2002) Long-term effects of Graves\u2019 ophthalmopathy on health-related quality of life. Eur J Endocrinol 146:751\u2013757","journal-title":"Eur J Endocrinol"},{"key":"555_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0161-6420(96)30579-4","volume":"103","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (1996) Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology 103:958\u2013962","journal-title":"Ophthalmology"},{"key":"555_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves\u2019 Orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"key":"555_CR6","first-page":"36","volume":"6","author":"FF Rundle","year":"1957","unstructured":"Rundle FF (1957) Management of exophthalmos and related ocular changes in Graves\u2019 disease. Metabolism 6:36\u201347","journal-title":"Metabolism"},{"key":"555_CR7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00843.x","volume":"51","author":"C Marcocci","year":"1999","unstructured":"Marcocci C, Bruno-Bossio G, Manetti L, Tanda ML, Miccoli P, Iacconi P, Bartolomei MP, Nardi M, Pinchera A, Bartalena L (1999) The course of Graves\u2019 ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) 51:503\u2013508","journal-title":"Clin Endocrinol (Oxf)"},{"key":"555_CR8","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","volume":"326","author":"L Tallstedt","year":"1992","unstructured":"Tallstedt L, Lundell G, T\u00f8rring O, Wallin G, Ljunggren JG, Blomgren H, Taube A, The Thyroid Study Group (1992) Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. N Engl J Med 326:1733\u20131738","journal-title":"N Engl J Med"},{"key":"555_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40618-015-0257-z","volume":"38","author":"L Bartalena","year":"2015","unstructured":"Bartalena L, Macchia PE, Marcocci C, Salvi M, Vermiglio F (2015) Effects of treatment modalities for Graves\u2019 hyperthyroidism on Graves\u2019 orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. J Endocrinol Invest 38:481\u2013487","journal-title":"J Endocrinol Invest"},{"key":"555_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1442-9071.2004.00756.x","volume":"32","author":"D Selva","year":"2004","unstructured":"Selva D, Chen C, King G (2004) Late reactivation of thyroid orbitopathy. Clin Exp Ophthalmol 32:46\u201350","journal-title":"Clin Exp Ophthalmol"},{"key":"555_CR11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1210\/jcem-29-7-982","volume":"29","author":"SC Werner","year":"1969","unstructured":"Werner SC (1969) Classification of the eye changes of Graves\u2019 disease. J Clin Endocrinol Metab 29:982\u2013984","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR12","first-page":"369","volume":"136","author":"PJ Agapitos","year":"1987","unstructured":"Agapitos PJ, Hart IR (1987) Long-term follow-up of ophthalmic Graves\u2019 disease. CMAJ 136:369\u2013372","journal-title":"CMAJ"},{"key":"555_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bmj.1.6056.273","volume":"1","author":"CS Teng","year":"1977","unstructured":"Teng CS, Yeo PP (1977) Ophthalmic Graves\u2019s disease: natural history and detailed thyroid function studies. Br Med J 1:273\u2013275","journal-title":"Br Med J"},{"key":"555_CR14","first-page":"603","volume":"131","author":"D Noth","year":"2001","unstructured":"Noth D, Gebauer M, M\u00fcller B, B\u00fcrgi U, Diem P (2001) Graves\u2019 ophthalmopathy: natural history and treatment outcomes. Swiss Med Wkly 131:603\u2013609","journal-title":"Swiss Med Wkly"},{"key":"555_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"Menconi F, Profilo MA, Leo M, Sisti E, Altea MA, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2014) Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited. Thyroid 24:60\u201366","journal-title":"Thyroid"},{"key":"555_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.1987.tb00848.x","volume":"27","author":"DH Streeten","year":"1987","unstructured":"Streeten DH, Anderson GH Jr, Reed GF, Woo P (1987) Prevalence, natural history and surgical treatment of exophthalmos. Clin Endocrinol (Oxf) 27:125\u2013133","journal-title":"Clin Endocrinol (Oxf)"},{"key":"555_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1995.tb02597.x","volume":"42","author":"P Perros","year":"1995","unstructured":"Perros P, Crombie AL, Kendall-Taylor P (1995) Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42:45\u201350","journal-title":"Clin Endocrinol (Oxf)"},{"key":"555_CR18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","volume":"98","author":"ML Tanda","year":"2013","unstructured":"Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed graves\u2019 hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98:1443\u20131449","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR19","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, European Group on Graves\u2019 Orbitopathy et al (2011) Selenium and the course of mild Graves\u2019 orbitopathy. N Engl J Med 364:1920\u20131931","journal-title":"N Engl J Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0555-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0555-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0555-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:33:18Z","timestamp":1498347198000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0555-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0555-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}